Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector

NCT03351829 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Beta-Thalassemia

Interventions

GENETIC: Gene-modified autologous stem cells

Sponsor

Shenzhen Geno-Immune Medical Institute